Chargement en cours...

Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes

BACKGROUND: In studying the therapeutic evidence of innovative drug treatments, increasing attention is being devoted to differentiating between results that indicate no significant differences among the treatments under examination (“no proof of difference”) and results that demonstrate the therape...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Messori, Andrea, Fadda, Valeria, Maratea, Dario, Trippoli, Sabrina, Marinai, Claudio
Format: Artigo
Langue:Inglês
Publié: Springer Healthcare 2014
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4065299/
https://ncbi.nlm.nih.gov/pubmed/24793219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-014-0066-y
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!